4dr Turbo Black 9-3 Leather Low Miles Low Price Warranty 1-owner Alloy Wheels on 2040-cars

Auto blog

NEVS mulling electric Saab 9-3 convertible, looking for engine partners, too

Do you believe in reincarnation? Like how we hope that, maybe, all of our hard work as auto writers will result in an eventual return as a swarm of beautiful butterflies. If you are a Saab fan, the equivalent could be this bit of news: The 9-3 Convertible may rise again, as an electric vehicle.
Word comes from the Dutch version of Autoweek that Chinese entity National Electric Vehicle Sweden (NEVS) has indicated that it will bring an electric version of the 9-3 Convertible to market in the next 18 months. The EV droptop would first debut in the Chinese market, but could expand, as could the lineup to other 9-3 variants, such as the sedan and SportCombi. A NEVS spokesperson has stated, "NEVS basically no doors holds." We're not sure if that's the spokesperson or the translation from the Dutch report, but you get the gist.
NEVS also indicated that conventionally powered versions of the 9-3 could be produced as well. The internal combustion engines could be the originally intended General Motors engines. Regardless of powerplant, we would be very eager to see Saab return, potentially as an EV to boot!

Saab has ruined all Swedish cars for me

It's easy to dismiss my hatred of all Swedish automotive manufacturers as a simple result of bad experiences. I mean, we're all products of our own experiences, some we learn from, others we don't, and some we need to be hit over the head with time and time again. I've been hit over the head too many times with Saabs (and one lonely Volvo), and as a result, I can't bring myself to buy a Koenigsegg. It started with a 900 Turbo sedan. You know, the ugly duckling sister of the beautiful two-door coupe that spawned the Aero, which managed to look stunning from the front, and like a child with a full nappy (diaper) at the rear. I bought it at an auction (mistake number one) for $6,500 (AUD) because as a bloke in his early twenties, I wanted to be noticed – and a greasy-haired bespectacled musician driving a turbocharged Swedish luxury car was my way of standing out. On the drive home I noticed two things: one, it handled like it was on rails – it just gripped! And two, the turbo wasn't working. I took my new wheels to the mechanic, who promptly told me a custom exhaust system would solve the problem – mistake number two. During the fitting, Mr. Shonky's Repair Shop managed to fry some computer thingy. I won't try to remember or understand what it was, but he did tell me that it should have been replaced and that I would have to pay for it. I agreed. Mistake number three. Twelve months later I had spent more than double the original purchase price on repairs, and the turbo still wouldn't work. I sold it for about $4,000, and moved on to something more sensible. But the beautiful handling and quirky design had left an itch that I just couldn't scratch. Many cars and motorbikes later, I sold my Mazda RX-8 because it was too perfect. You know those cars that have spotless paint, an unmarked interior, low kilometers, and you're just too damn scared to park it anywhere? Yep, it was one of those. I would spend 30 to 40 minutes trying to find a vacant spot with vacant spots on either side, and even after leaving the car I would walk back to check if anyone had parked next to me. If they did, I moved. Not a low-anxiety vehicle. So I bought my second Saab – this time a 9-5 turbo wagon – from an auction. Wasn't that mistake number one? This one had reasonably low kilometers, and was even on LPG (a fairly common conversion is Australia – just not on Saabs) and only set me back $2,200. I drove it home, and low and behold, the turbo worked!

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.